153 related articles for article (PubMed ID: 32863999)
1. A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients.
Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
Arch Med Sci; 2020; 16(5):1104-1110. PubMed ID: 32863999
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma.
Yu WM; Li GW; Lou MG; Wu ZY
BMC Gastroenterol; 2023 Nov; 23(1):401. PubMed ID: 37978447
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis.
Zhao S; Long M; Zhang X; Lei S; Dou W; Hu J; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):536. PubMed ID: 32411759
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.
Liu H; Yang C; Lu W; Zeng Y
Medicine (Baltimore); 2018 Jan; 97(4):e9702. PubMed ID: 29369198
[TBL] [Abstract][Full Text] [Related]
8. The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis.
Min Z; Xunlei Z; Haizhen C; Wenjing Z; Haiyan Y; Xiaoyun L; Jianyun Z; Xudong C; Aiguo S
Front Bioinform; 2021; 1():706835. PubMed ID: 36303795
[No Abstract] [Full Text] [Related]
9. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
Medicine (Baltimore); 2018 Jun; 97(24):e11130. PubMed ID: 29901640
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Zhang J; Chang L; Zhang X; Zhou Z; Gao Y
J Invest Surg; 2021 Mar; 34(3):297-306. PubMed ID: 31412745
[No Abstract] [Full Text] [Related]
11. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.
Dai M; Chen X; Liu X; Peng Z; Meng J; Dai S
PLoS One; 2015; 10(10):e0140067. PubMed ID: 26441340
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis.
Liang C; Zhao J; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():3561-3571. PubMed ID: 29950861
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Qi CY; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():104. PubMed ID: 24548704
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.
Zhang CH; Xu GL; Jia WD; Ge YS; Li JS; Ma JL; Ren WH
Int J Cancer; 2012 Jun; 130(11):2685-92. PubMed ID: 21780114
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysis.
Sun DW; Zhang YY; Sun XD; Chen YG; Qiu W; Ji M; Lv GY
Clin Chim Acta; 2015 Aug; 448():161-9. PubMed ID: 26164382
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma.
Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H
Virusdisease; 2019 Jun; 30(2):193-200. PubMed ID: 31179356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
